An Overview of Quadrivalent Human Papillomavirus Vaccine Safety-Reference-Cited by-同舟云学术

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety

Published:2015-09 Issue:9 Volume:34 Page:983-991
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Vichnin Michelle,Bonanni Paolo,Klein Nicola P.,Garland Suzanne M.,Block Stan L.,Kjaer Susanne K.,Sings Heather L.,Perez Gonzalo,Haupt Richard M.,Saah Alfred J.,Lievano Fabio,Velicer Christine,Drury Rosybel,Kuter Barbara J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference59 articles.

1. Females United to Unilaterally Reduce EndoEctocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.;Garland;N Engl J Med,2007

2. Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.;Block;Pediatrics,2006

3. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.;Reisinger;Pediatr Infect Dis J,2007

4. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.;Giuliano;N Engl J Med,2011

5. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.;Palefsky;N Engl J Med,2011

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stakeholders’ Perceptions on the Implementation of the HPV Vaccine School-Entry Requirement in Puerto Rico during the COVID-19 Pandemic;Vaccines;2024-07-10

2. COVID-19’s myths, facts, concerning and obstinate posts on social network, and the mental health status of social network users in Bangladesh;PLOS Mental Health;2024-06-24

3. Implementing a School-Entry Mandate for the Human Papillomavirus Vaccine: Benefits and Challenges;Cureus;2024-06-17

4. Stakeholders’ experiences with school-based immunization programs during the COVID-19 pandemic in the Canadian Maritimes: A qualitative study;Public Health in Practice;2024-06

5. Vacciner nos enfants contre le papillomavirus : une question de santé publique !;Revue Francophone des Laboratoires;2024-03